GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BUE:BMY) » Definitions » Cyclically Adjusted PS Ratio

Bristol-Myers Squibb Co (BUE:BMY) Cyclically Adjusted PS Ratio : 2.19 (As of Jun. 01, 2025)


View and export this data going back to . Start your Free Trial

What is Bristol-Myers Squibb Co Cyclically Adjusted PS Ratio?

As of today (2025-06-01), Bristol-Myers Squibb Co's current share price is ARS19400.00. Bristol-Myers Squibb Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ARS8,870.76. Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio for today is 2.19.

The historical rank and industry rank for Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

BUE:BMY' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.08   Med: 4.62   Max: 7
Current: 2.4

During the past years, Bristol-Myers Squibb Co's highest Cyclically Adjusted PS Ratio was 7.00. The lowest was 2.08. And the median was 4.62.

BUE:BMY's Cyclically Adjusted PS Ratio is ranked worse than
54.07% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.12 vs BUE:BMY: 2.40

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted revenue per share data for the three months ended in Mar. 2025 was ARS5,853.274. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ARS8,870.76 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bristol-Myers Squibb Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Cyclically Adjusted PS Ratio Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.67 4.21 4.34 2.85 2.88

Bristol-Myers Squibb Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.91 2.18 2.67 2.88 3.03

Competitive Comparison of Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio falls into.


;
;

Bristol-Myers Squibb Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=19400.00/8870.76
=2.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Bristol-Myers Squibb Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=5853.274/134.9266*134.9266
=5,853.274

Current CPI (Mar. 2025) = 134.9266.

Bristol-Myers Squibb Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 22.692 100.684 30.410
201509 22.800 100.392 30.643
201512 32.930 99.792 44.524
201603 38.170 100.470 51.260
201606 40.557 101.688 53.814
201609 43.729 101.861 57.924
201612 49.385 101.863 65.415
201703 45.476 102.862 59.652
201706 51.403 103.349 67.109
201709 55.969 104.136 72.518
201712 63.328 104.011 82.151
201803 63.801 105.290 81.760
201806 86.955 106.317 110.355
201809 128.009 106.507 162.167
201812 137.576 105.998 175.123
201903 141.364 107.251 177.843
201906 171.210 108.070 213.759
201909 205.598 108.329 256.077
201912 244.794 108.420 304.641
202003 296.355 108.902 367.177
202006 306.421 108.767 380.117
202009 341.699 109.815 419.836
202012 399.962 109.897 491.056
202103 440.378 111.754 531.690
202106 492.285 114.631 579.443
202109 506.730 115.734 590.761
202112 544.964 117.630 625.099
202203 577.943 121.301 642.863
202206 665.595 125.017 718.355
202209 725.671 125.227 781.882
202212 901.138 125.222 970.977
202303 1,059.926 127.348 1,123.005
202306 1,281.751 128.729 1,343.463
202309 1,859.279 129.860 1,931.828
202312 2,037.972 129.419 2,124.694
202403 4,941.306 131.776 5,059.439
202406 5,384.916 132.554 5,481.310
202409 5,565.409 133.029 5,644.801
202412 6,140.601 133.157 6,222.202
202503 5,853.274 134.927 5,853.274

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bristol-Myers Squibb Co  (BUE:BMY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bristol-Myers Squibb Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co Business Description

Address
Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.